|
|
| Issue Open | Nov 9, 2020 |
| Issue Close | Nov 11, 2020 |
| IPO Price | ₹1500 |
| Face Value | ₹1 |
| IPO Size | ₹6,479.55 Cr |
| Listing At | BSE, NSE |
| IPO Lot Size | 10 |
Gland Pharma IPO subscribed 2.06 times. The public issue subscribed 0.24 times in the retail category, 6.40 times in QIB, and 0.51 times in the NII category by Nov 11, 2020.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutions | 6.40 |
| Non-Institutional Buyers | 0.51 |
| Retail Investors | 0.24 |
| Employees | [.] |
| Others | [.] |
| Total | 2.06 |
| Date | QIB | NII | Retail | Total |
|---|---|---|---|---|
Day 1 | 0.00 | 0.01 | 0.08 | 0.04 |
Day 2 | 0.48 | 0.03 | 0.15 | 0.22 |
Day 3 | 6.40 | 0.51 | 0.24 | 2.06 |
Gland Pharma IPO is a public issue of 30,237,879 equity shares. The issue offers 15,118,939 shares to retail investors, 8,639,394 shares to qualified institutional buyers, and 6,479,546 shares to non-institutional investors.
| Category | Shares Offered | % |
|---|---|---|
| QIB | 8,639,394 | 28.57% |
| NII | 6,479,546 | 21.43% |
| Retail | 15,118,939 | 50.00% |
| Total | 30,237,879 | 100% |
Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.
Individual investors, NRIs, companies, trusts, etc who bid for more than Rs 2 lakhs are known as Non-institutional bidders or NII. They need not register with SEBI like QIIs.
The retail individual investor or NRIs who apply up to Rs 2,00,000 in an IPO are considered as RII reserved category.
A category of eligible employees who have a reserved quota in the IPO.
A category of eligible shareholders or other investors who have a reserved quota in the IPO.
The Gland Pharma IPO is subscribed 2.06 by Nov 11, 2020.
| Investor Category | Subscription (times) |
|---|---|
| Qualified Institutional | 6.40 |
| Non Institutional | 0.51 |
| Retail Individual | 0.24 |
| Employee Reservations | [.] |
| Others | [.] |
| Total Subscription | 2.06 |
An investor can apply in Gland Pharma IPO online via bank (using ASBA) or the broker (using UPI). The Gland Pharma IPO shares are offered online only.
The Gland Pharma IPO is subscribed 2.06 by Nov 11, 2020.
The Gland Pharma IPO allotment status is expected on or around Nov 17, 2020. Visit Gland Pharma IPO allotment status to check.
Visit Gland Pharma IPO subscription status page for real-time bidding information about Gland Pharma IPO.
| IPO Opens On | Nov 9, 2020 |
| IPO Closes On | Nov 11, 2020 |
| Finalisation of Basis of Allotment | Nov 17, 2020 |
| Initiation of Refunds | Nov 18, 2020 |
| Credit of Shares to Demat Account | Nov 19, 2020 |
| IPO Listing Date | Nov 20, 2020 |
Useful Articles
Rs 0 Eq Delivery Brokerage
Flat ₹10 Per Trade in F&O
Rs 0 Demat AMC
